company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q1,2010-07-01,2010-09-30,2011-11-04 16:27:29+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6465529.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q1,2010-07-01,2010-09-30,2011-11-04 16:27:29+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6465529.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q1,2010-07-01,2010-09-30,2011-11-04 16:27:29+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,405704.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q1,2010-07-01,2010-09-30,2011-11-04 16:27:29+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-33019.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q1,2010-07-01,2010-09-30,2011-11-04 16:27:29+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,271818.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q1,2010-07-01,2010-09-30,2011-11-04 16:27:29+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1283914.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q1,2010-07-01,2010-09-30,2011-11-04 16:27:29+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7104940.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q1,2010-07-01,2010-09-30,2011-11-04 16:27:29+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7104940.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q1,2010-07-01,2010-09-30,2011-11-04 16:27:29+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-312055.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q1,2010-07-01,2010-09-30,2011-11-04 16:27:29+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,957000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q1,2010-07-01,2010-09-30,2011-11-04 16:27:29+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,100000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q1,2010-07-01,2010-09-30,2011-11-04 16:27:29+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,744945.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q1,2010-07-01,2010-09-30,2011-11-04 16:27:29+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,744945.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q1,2010-07-01,2010-09-30,2011-11-04 16:27:29+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,5525.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q1,2010-07-01,2010-09-30,2011-11-04 16:27:29+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5525.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q1,2010-07-01,2010-09-30,2011-11-04 16:27:29+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5525.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q1,2010-07-01,2010-09-30,2011-11-04 16:27:29+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-6354470.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q2,2010-10-01,2010-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3427386.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q2,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3427386.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q2,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,405806.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q2,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-33807.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q2,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,385455.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q2,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,869561.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q2,2010-10-01,2010-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-1800371.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q2,2010-10-01,2010-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-1800371.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q2,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-48850.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q2,2010-10-01,2010-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-48850.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q2,2010-10-01,2010-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-48850.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q2,2010-10-01,2010-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1849221.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q3,2011-01-01,2011-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7603150.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q3,2011-01-01,2011-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7603150.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q3,2011-01-01,2011-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,283713.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q3,2011-01-01,2011-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,26644.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q3,2011-01-01,2011-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,20633.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q3,2011-01-01,2011-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,936032.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q3,2011-01-01,2011-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6336128.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q3,2011-01-01,2011-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6336128.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q3,2011-01-01,2011-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-37538.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q3,2011-01-01,2011-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,8588000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q3,2011-01-01,2011-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,151151.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q3,2011-01-01,2011-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,8701613.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q3,2011-01-01,2011-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,8701613.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q3,2011-01-01,2011-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,6699.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q3,2011-01-01,2011-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,6699.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q3,2011-01-01,2011-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,6699.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q3,2011-01-01,2011-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2372184.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q4,2011-04-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2251658.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q4,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2251658.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q4,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,382416.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q4,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-79932.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q4,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,417335.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q4,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,83945.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q4,2011-04-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3055422.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q4,2011-04-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3055422.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q4,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-207545.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q4,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,27859.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q4,2011-04-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-179686.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q4,2011-04-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-179686.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q4,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,135177.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q4,2011-04-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,135177.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q4,2011-04-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,135177.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q4,2011-04-01,2011-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,384974.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q4,2011-04-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3395887.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q4,2011-04-01,2011-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,441531.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q1,2011-07-01,2011-09-30,2012-11-08 16:15:44+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5126881.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q1,2011-07-01,2011-09-30,2012-11-08 16:15:44+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5126881.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q1,2011-07-01,2011-09-30,2012-11-08 16:15:44+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,367552.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q1,2011-07-01,2011-09-30,2012-11-08 16:15:44+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,75282.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q1,2011-07-01,2011-09-30,2012-11-08 16:15:44+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,432309.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q1,2011-07-01,2011-09-30,2012-11-08 16:15:44+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1801983.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q1,2011-07-01,2011-09-30,2012-11-08 16:15:44+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6053721.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q1,2011-07-01,2011-09-30,2012-11-08 16:15:44+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6053721.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q1,2011-07-01,2011-09-30,2012-11-08 16:15:44+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-193032.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q1,2011-07-01,2011-09-30,2012-11-08 16:15:44+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,0.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q1,2011-07-01,2011-09-30,2012-11-08 16:15:44+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-193032.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q1,2011-07-01,2011-09-30,2012-11-08 16:15:44+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-193032.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q1,2011-07-01,2011-09-30,2012-11-08 16:15:44+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-26927.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q1,2011-07-01,2011-09-30,2012-11-08 16:15:44+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,5286.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q1,2011-07-01,2011-09-30,2012-11-08 16:15:44+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-21641.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q1,2011-07-01,2011-09-30,2012-11-08 16:15:44+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-21641.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q1,2011-07-01,2011-09-30,2012-11-08 16:15:44+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-178488.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q1,2011-07-01,2011-09-30,2012-11-08 16:15:44+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-6446882.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q2,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,20666930.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q2,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,20666930.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q2,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,367456.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q2,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,41680.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q2,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-27812855.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q2,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2622037.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q2,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4114752.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q2,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4114752.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q2,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-108979.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q2,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-108979.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q2,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-108979.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q2,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-22765.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q2,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,10006.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q2,2011-10-01,2011-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-12759.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q2,2011-10-01,2011-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-12759.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q2,2011-10-01,2011-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-79828.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q2,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4316318.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q3,2012-01-01,2012-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7297986.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q3,2012-01-01,2012-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7297986.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q3,2012-01-01,2012-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,368640.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q3,2012-01-01,2012-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,24879.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q3,2012-01-01,2012-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,28931454.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q3,2012-01-01,2012-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-850771.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q3,2012-01-01,2012-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,21176216.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q3,2012-01-01,2012-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,21176216.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q3,2012-01-01,2012-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-76037.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q3,2012-01-01,2012-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-76037.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q3,2012-01-01,2012-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-76037.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q3,2012-01-01,2012-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-25974.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q3,2012-01-01,2012-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1582000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q3,2012-01-01,2012-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1556026.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q3,2012-01-01,2012-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1556026.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q3,2012-01-01,2012-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,60020.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q3,2012-01-01,2012-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,22716225.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q4,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6977228.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q4,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6977228.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q4,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,393135.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q4,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-270797.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q4,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,531828.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q4,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,223642.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q4,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6099420.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q4,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6099420.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q4,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-190085.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q4,2012-04-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-190085.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q4,2012-04-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-190085.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q4,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,75666.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q4,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,58145.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q4,2012-04-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,133811.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q4,2012-04-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,133811.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q4,2012-04-01,2012-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-56845.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q4,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-6212539.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q4,2012-04-01,2012-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,23144.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q1,2012-07-01,2012-09-30,2014-03-18 20:52:51+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7166817.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q1,2012-07-01,2012-09-30,2014-03-18 20:52:51+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7166817.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q1,2012-07-01,2012-09-30,2014-03-18 20:52:51+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,239285.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q1,2012-07-01,2012-09-30,2014-03-18 20:52:51+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,24879.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q1,2012-07-01,2012-09-30,2014-03-18 20:52:51+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,335292.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q1,2012-07-01,2012-09-30,2014-03-18 20:52:51+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-820723.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q1,2012-07-01,2012-09-30,2014-03-18 20:52:51+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7388084.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q1,2012-07-01,2012-09-30,2014-03-18 20:52:51+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7388084.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q1,2012-07-01,2012-09-30,2014-03-18 20:52:51+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-97721.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q1,2012-07-01,2012-09-30,2014-03-18 20:52:51+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,137714.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q1,2012-07-01,2012-09-30,2014-03-18 20:52:51+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,39993.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q1,2012-07-01,2012-09-30,2014-03-18 20:52:51+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,39993.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q1,2012-07-01,2012-09-30,2014-03-18 20:52:51+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-138029.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q1,2012-07-01,2012-09-30,2014-03-18 20:52:51+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,59071.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q1,2012-07-01,2012-09-30,2014-03-18 20:52:51+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-78958.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q1,2012-07-01,2012-09-30,2014-03-18 20:52:51+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-78958.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q1,2012-07-01,2012-09-30,2014-03-18 20:52:51+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,109271.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q1,2012-07-01,2012-09-30,2014-03-18 20:52:51+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7317778.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q2,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5189642.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q2,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5189642.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q2,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,238819.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q2,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,24879.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q2,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,723390.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q2,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,248057.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q2,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3954497.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q2,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3954497.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q2,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-96436.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q2,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,165.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q2,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-96271.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q2,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-96271.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q2,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-74330.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q2,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2033.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q2,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-72297.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q2,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-72297.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q2,2012-10-01,2012-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,2590.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q2,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4120475.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q3,2013-01-01,2013-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,8580820.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q3,2013-01-01,2013-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8580820.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q3,2013-01-01,2013-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,287109.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q3,2013-01-01,2013-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-151788.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q3,2013-01-01,2013-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,519473.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q3,2013-01-01,2013-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2678872.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q3,2013-01-01,2013-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,11914486.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q3,2013-01-01,2013-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,11914486.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q3,2013-01-01,2013-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-219018.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q3,2013-01-01,2013-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-219018.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q3,2013-01-01,2013-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-219018.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q3,2013-01-01,2013-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-30570.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q3,2013-01-01,2013-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,14789375.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q3,2013-01-01,2013-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q3,2013-01-01,2013-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,14758804.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q3,2013-01-01,2013-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,14758804.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q3,2013-01-01,2013-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-56429.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q3,2013-01-01,2013-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,26397843.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q4,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7710645.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q4,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7710645.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q4,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,270822.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q4,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,102030.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q4,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,367215.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q4,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,499115.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q4,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6471463.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q4,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6471463.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q4,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-182271.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q4,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-182271.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q4,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-182271.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q4,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,157694.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q4,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,157694.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q4,2013-04-01,2013-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,24354.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q4,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-6471686.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q4,2013-04-01,2013-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,135023.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q2,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8897679.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q2,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8897679.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q2,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,157188.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q2,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-2364816.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q2,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3624725.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q2,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-379586.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q2,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7860168.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q2,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7860168.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q2,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-69495.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q2,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-44335.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q2,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-113830.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q2,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-113830.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q2,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,107975.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q2,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,107975.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q2,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,107975.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q2,2013-10-01,2013-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,32921.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q2,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7833102.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q3,2014-01-01,2014-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9533961.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q3,2014-01-01,2014-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9533961.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q3,2014-01-01,2014-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,109708.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q3,2014-01-01,2014-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,37838.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q3,2014-01-01,2014-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,887512.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q3,2014-01-01,2014-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2181331.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q3,2014-01-01,2014-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6317572.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q3,2014-01-01,2014-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6317572.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q3,2014-01-01,2014-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-103312.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q3,2014-01-01,2014-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,30044.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q3,2014-01-01,2014-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,4015460.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q3,2014-01-01,2014-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,3942192.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q3,2014-01-01,2014-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,3942192.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q3,2014-01-01,2014-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,517344.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q3,2014-01-01,2014-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,517344.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q3,2014-01-01,2014-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,517344.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q3,2014-01-01,2014-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,37727.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q3,2014-01-01,2014-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1820309.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q4,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11873355.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q4,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11873355.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q4,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,145358.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q4,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-44521.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q4,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,797333.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q4,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1726242.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q4,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9248943.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q4,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9248943.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q4,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-60435.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q4,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-24018842.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q4,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5008685.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q4,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,400000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q4,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-18670592.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q4,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-18670592.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q4,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,29809448.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q4,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,91061.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q4,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,29900509.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q4,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,29900509.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q4,2014-04-01,2014-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-9119.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q4,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1971855.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q4,2014-04-01,2014-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,136973.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q1,2014-07-01,2014-09-30,2015-11-04 16:30:27+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12442762.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q1,2014-07-01,2014-09-30,2015-11-04 16:30:27+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12442762.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q1,2014-07-01,2014-09-30,2015-11-04 16:30:27+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,140817.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q1,2014-07-01,2014-09-30,2015-11-04 16:30:27+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,163464.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q1,2014-07-01,2014-09-30,2015-11-04 16:30:27+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,553895.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q1,2014-07-01,2014-09-30,2015-11-04 16:30:27+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2477688.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q1,2014-07-01,2014-09-30,2015-11-04 16:30:27+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9106898.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q1,2014-07-01,2014-09-30,2015-11-04 16:30:27+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9106898.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q1,2014-07-01,2014-09-30,2015-11-04 16:30:27+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-331750.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q1,2014-07-01,2014-09-30,2015-11-04 16:30:27+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,8196588.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q1,2014-07-01,2014-09-30,2015-11-04 16:30:27+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,7864838.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q1,2014-07-01,2014-09-30,2015-11-04 16:30:27+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,7864838.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q1,2014-07-01,2014-09-30,2015-11-04 16:30:27+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-86571.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q1,2014-07-01,2014-09-30,2015-11-04 16:30:27+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-86571.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q1,2014-07-01,2014-09-30,2015-11-04 16:30:27+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-86571.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q1,2014-07-01,2014-09-30,2015-11-04 16:30:27+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-187388.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q1,2014-07-01,2014-09-30,2015-11-04 16:30:27+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1516019.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q2,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11465650.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q2,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11465650.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q2,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,140817.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q2,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,108046.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q2,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,951336.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q2,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-201960.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q2,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-10467411.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q2,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-10467411.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q2,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-107849.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q2,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3244370.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q2,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,11281509.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q2,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,7929290.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q2,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,7929290.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q2,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-53761.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q2,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-53761.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q2,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-53761.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q2,2014-10-01,2014-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-4903.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q2,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2596785.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q3,2015-01-01,2015-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11788150.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q3,2015-01-01,2015-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11788150.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q3,2015-01-01,2015-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,127009.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q3,2015-01-01,2015-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,200292.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q3,2015-01-01,2015-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,655853.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q3,2015-01-01,2015-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-238.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q3,2015-01-01,2015-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-10805234.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q3,2015-01-01,2015-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-10805234.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q3,2015-01-01,2015-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-141929.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q3,2015-01-01,2015-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-79054426.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q3,2015-01-01,2015-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,7270674.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q3,2015-01-01,2015-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-71925681.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q3,2015-01-01,2015-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-71925681.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q3,2015-01-01,2015-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-3657214.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q3,2015-01-01,2015-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,100000000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q3,2015-01-01,2015-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,126348.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q3,2015-01-01,2015-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,96469134.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q3,2015-01-01,2015-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,96469134.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q3,2015-01-01,2015-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-523750.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q3,2015-01-01,2015-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,13214469.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q4,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12427409.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q4,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12427409.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q4,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,169423.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q4,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,448001.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q4,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,737690.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q4,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2455629.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q4,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8616666.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q4,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8616666.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q4,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-342901.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q4,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4008275.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q4,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,7742382.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q4,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,3391206.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q4,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,3391206.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q4,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q4,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2388189.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q4,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2388188.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q4,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2388188.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q4,2015-04-01,2015-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,226888.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q4,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2610384.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q4,2015-04-01,2015-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,75598.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q1,2015-07-01,2015-09-30,2016-11-02 16:51:34+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15416039.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q1,2015-07-01,2015-09-30,2016-11-02 16:51:34+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15416039.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q1,2015-07-01,2015-09-30,2016-11-02 16:51:34+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,167865.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q1,2015-07-01,2015-09-30,2016-11-02 16:51:34+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,402265.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q1,2015-07-01,2015-09-30,2016-11-02 16:51:34+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,894843.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q1,2015-07-01,2015-09-30,2016-11-02 16:51:34+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,601599.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q1,2015-07-01,2015-09-30,2016-11-02 16:51:34+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13349467.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q1,2015-07-01,2015-09-30,2016-11-02 16:51:34+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13349467.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q1,2015-07-01,2015-09-30,2016-11-02 16:51:34+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-689941.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q1,2015-07-01,2015-09-30,2016-11-02 16:51:34+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2000000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q1,2015-07-01,2015-09-30,2016-11-02 16:51:34+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,14292088.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q1,2015-07-01,2015-09-30,2016-11-02 16:51:34+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,11602147.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q1,2015-07-01,2015-09-30,2016-11-02 16:51:34+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,11602147.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q1,2015-07-01,2015-09-30,2016-11-02 16:51:34+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,58700.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q1,2015-07-01,2015-09-30,2016-11-02 16:51:34+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,58700.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q1,2015-07-01,2015-09-30,2016-11-02 16:51:34+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,58700.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q1,2015-07-01,2015-09-30,2016-11-02 16:51:34+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,20919.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q1,2015-07-01,2015-09-30,2016-11-02 16:51:34+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1667701.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q1,2015-07-01,2015-09-30,2016-11-02 16:51:34+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,2427778.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q2,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13772622.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q2,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13772622.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q2,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,168262.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q2,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,391359.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q2,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1069129.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q2,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3669883.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q2,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8473989.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q2,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8473989.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q2,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-540785.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q2,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-749117.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q2,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,11836000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q2,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,10546098.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q2,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,10546098.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q2,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-86120.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q2,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-86120.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q2,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-86120.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q2,2015-10-01,2015-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-54856.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q2,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1931133.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q3,2016-01-01,2016-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14021676.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q3,2016-01-01,2016-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14021676.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q3,2016-01-01,2016-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,168653.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q3,2016-01-01,2016-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,360604.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q3,2016-01-01,2016-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,895310.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q3,2016-01-01,2016-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1497608.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q3,2016-01-01,2016-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-14094717.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q3,2016-01-01,2016-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-14094717.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q3,2016-01-01,2016-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-200033.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q3,2016-01-01,2016-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,11892000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q3,2016-01-01,2016-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,11691967.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q3,2016-01-01,2016-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,11691967.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q3,2016-01-01,2016-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-131891.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q3,2016-01-01,2016-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-131891.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q3,2016-01-01,2016-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-131891.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q3,2016-01-01,2016-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,27743.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q3,2016-01-01,2016-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2506898.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q3,2016-01-01,2016-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,2375000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q4,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15925379.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q4,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15925379.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q4,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,232881.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q4,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,142879.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q4,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,920335.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q4,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2085657.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q4,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12543627.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q4,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12543627.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q4,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-795497.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q4,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,12830000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q4,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,12034503.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q4,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,12034503.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q4,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2523289.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q4,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2523289.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q4,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2523289.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q4,2016-04-01,2016-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-19849.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q4,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1994316.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q4,2016-04-01,2016-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,28679.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q1,2016-07-01,2016-09-30,2017-11-09 16:44:17+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16228893.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q1,2016-07-01,2016-09-30,2017-11-09 16:44:17+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16228893.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q1,2016-07-01,2016-09-30,2017-11-09 16:44:17+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,225862.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q1,2016-07-01,2016-09-30,2017-11-09 16:44:17+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,261727.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q1,2016-07-01,2016-09-30,2017-11-09 16:44:17+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,778492.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q1,2016-07-01,2016-09-30,2017-11-09 16:44:17+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1845553.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q1,2016-07-01,2016-09-30,2017-11-09 16:44:17+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-16808365.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q1,2016-07-01,2016-09-30,2017-11-09 16:44:17+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-16808365.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q1,2016-07-01,2016-09-30,2017-11-09 16:44:17+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-647572.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q1,2016-07-01,2016-09-30,2017-11-09 16:44:17+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,12712000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q1,2016-07-01,2016-09-30,2017-11-09 16:44:17+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,12064428.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q1,2016-07-01,2016-09-30,2017-11-09 16:44:17+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,12064428.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q1,2016-07-01,2016-09-30,2017-11-09 16:44:17+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-96.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q1,2016-07-01,2016-09-30,2017-11-09 16:44:17+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-96.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q1,2016-07-01,2016-09-30,2017-11-09 16:44:17+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-96.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q1,2016-07-01,2016-09-30,2017-11-09 16:44:17+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,5015.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q1,2016-07-01,2016-09-30,2017-11-09 16:44:17+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4739018.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q1,2016-07-01,2016-09-30,2017-11-09 16:44:17+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,2375000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q2,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24448163.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q2,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24448163.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q2,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,233540.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q2,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,237539.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q2,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7866875.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q2,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1410169.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q2,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-14700040.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q2,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-14700040.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q2,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-83055.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q2,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-29160546.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q2,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,12038000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q2,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-17205601.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q2,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-17205601.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q2,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,28578473.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q2,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-88821.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q2,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,28489652.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q2,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,28489652.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q2,2016-10-01,2016-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-37302.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q2,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3453291.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q3,2017-01-01,2017-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-59320358.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q3,2017-01-01,2017-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-59320358.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q3,2017-01-01,2017-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,173677.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q3,2017-01-01,2017-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-113741.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q3,2017-01-01,2017-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,37096075.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q3,2017-01-01,2017-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,5492497.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q3,2017-01-01,2017-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-16671850.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q3,2017-01-01,2017-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-16677332.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q3,2017-01-01,2017-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-98698.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q3,2017-01-01,2017-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,17490521.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q3,2017-01-01,2017-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,17391823.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q3,2017-01-01,2017-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,17391823.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q3,2017-01-01,2017-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,14700000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q3,2017-01-01,2017-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1453072.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q3,2017-01-01,2017-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,16153072.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q3,2017-01-01,2017-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,16153072.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q3,2017-01-01,2017-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,19589.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q3,2017-01-01,2017-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,16887152.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q3,2017-01-01,2017-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,2375000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q4,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-53268586.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q4,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-53268586.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q4,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,289921.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q4,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,498475.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q4,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,27615558.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q4,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,10794887.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q4,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-14069745.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q4,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-14064263.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q4,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1007675.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q4,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-102449454.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q4,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,14942479.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q4,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-88514650.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q4,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-88514650.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q4,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,121782000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q4,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-473.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q4,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2379845.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q4,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,124161372.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q4,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,124161372.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q4,2017-04-01,2017-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,12698.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q4,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,21595157.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q4,2017-04-01,2017-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,24000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q1,2017-07-01,2017-09-30,2018-11-07 16:16:01+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-118762000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q1,2017-07-01,2017-09-30,2018-11-07 16:16:01+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-118762000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q1,2017-07-01,2017-09-30,2018-11-07 16:16:01+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,213000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q1,2017-07-01,2017-09-30,2018-11-07 16:16:01+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1538000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q1,2017-07-01,2017-09-30,2018-11-07 16:16:01+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,99970000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q1,2017-07-01,2017-09-30,2018-11-07 16:16:01+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3529000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q1,2017-07-01,2017-09-30,2018-11-07 16:16:01+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-20570000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q1,2017-07-01,2017-09-30,2018-11-07 16:16:01+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-20570000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q1,2017-07-01,2017-09-30,2018-11-07 16:16:01+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-789000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q1,2017-07-01,2017-09-30,2018-11-07 16:16:01+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-245000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q1,2017-07-01,2017-09-30,2018-11-07 16:16:01+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,15124000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q1,2017-07-01,2017-09-30,2018-11-07 16:16:01+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,14090000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q1,2017-07-01,2017-09-30,2018-11-07 16:16:01+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,14090000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q1,2017-07-01,2017-09-30,2018-11-07 16:16:01+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-419000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q1,2017-07-01,2017-09-30,2018-11-07 16:16:01+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,5906000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q1,2017-07-01,2017-09-30,2018-11-07 16:16:01+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,561000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q1,2017-07-01,2017-09-30,2018-11-07 16:16:01+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,6048000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q1,2017-07-01,2017-09-30,2018-11-07 16:16:01+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,6048000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q1,2017-07-01,2017-09-30,2018-11-07 16:16:01+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-2000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q1,2017-07-01,2017-09-30,2018-11-07 16:16:01+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-434000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q1,2017-07-01,2017-09-30,2018-11-07 16:16:01+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,2375000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q2,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2527442.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q2,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2527442.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q2,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,414687.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q2,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-28187.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q2,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-26008724.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q2,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-15059297.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q2,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-43208963.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q2,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-43208963.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q2,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1200626.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q2,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-9999890.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q2,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,27837482.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q2,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,16636966.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q2,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,16636966.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q2,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-108258.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q2,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,44569941.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q2,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,52964.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q2,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,44514647.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q2,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,44514647.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q2,2017-10-01,2017-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,57914.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q2,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,18000564.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q3,2018-01-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-95517558.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q3,2018-01-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-95517558.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q3,2018-01-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,633313.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q3,2018-01-01,2018-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-1442813.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q3,2018-01-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7794724.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q3,2018-01-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,33012297.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q3,2018-01-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-55520037.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q3,2018-01-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-55520037.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q3,2018-01-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-9179374.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q3,2018-01-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,10109890.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q3,2018-01-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,31006518.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q3,2018-01-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,31937034.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q3,2018-01-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,31937034.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q3,2018-01-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-3000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q3,2018-01-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,527258.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q3,2018-01-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,182216000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q3,2018-01-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,316775059.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q3,2018-01-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,27569036.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q3,2018-01-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,527084353.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q3,2018-01-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,527084353.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q3,2018-01-01,2018-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-55914.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q3,2018-01-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,503445436.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q3,2018-01-01,2018-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,-1425000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q4,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-57080000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q4,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-57080000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q4,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,36000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q4,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1566000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q4,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,63691000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q4,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-22340000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q4,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-14127000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q4,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-14127000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q4,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,1194000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q4,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-10245000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q4,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,21144000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q4,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,12093000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q4,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,12093000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q4,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-527000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q4,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,50783000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q4,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,50256000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q4,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,50256000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q4,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,48222000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q4,2018-04-01,2018-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,1900000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q1,2018-07-01,2019-03-31,2020-05-06 16:08:51+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-87404000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q1,2018-07-01,2019-03-31,2020-05-06 16:08:51+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-87404000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q1,2018-07-01,2019-03-31,2020-05-06 16:08:51+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,804000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q1,2018-07-01,2019-03-31,2020-05-06 16:08:51+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,13000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q1,2018-07-01,2019-03-31,2020-05-06 16:08:51+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,11769000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q1,2018-07-01,2019-03-31,2020-05-06 16:08:51+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,20141000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q1,2018-07-01,2019-03-31,2020-05-06 16:08:51+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-54677000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q1,2018-07-01,2019-03-31,2020-05-06 16:08:51+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-54677000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q1,2018-07-01,2019-03-31,2020-05-06 16:08:51+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2064000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q1,2018-07-01,2019-03-31,2020-05-06 16:08:51+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2064000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q1,2018-07-01,2019-03-31,2020-05-06 16:08:51+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2064000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q1,2018-07-01,2019-03-31,2020-05-06 16:08:51+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1825000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q1,2018-07-01,2019-03-31,2020-05-06 16:08:51+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1825000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q1,2018-07-01,2019-03-31,2020-05-06 16:08:51+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1825000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q1,2018-07-01,2019-03-31,2020-05-06 16:08:51+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-54925000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q1,2018-07-01,2019-03-31,2020-05-06 16:08:51+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,169000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-75953000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-75953000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1035000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,142000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,12751000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,49529000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12496000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12496000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3635000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3635000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3635000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,5829000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,281000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,6110000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,6110000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-10012000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-94323000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-94323000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,992000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,79000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,13832000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,16815000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-62605000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-62605000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-815000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-815000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-815000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,175000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,175000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,175000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-63245000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q3,2019-07-01,2019-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,169000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-99639000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-99639000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,991000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,80000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,14316000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-8412000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-92664000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-92664000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-335000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q4,2019-10-01,2019-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-335000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-335000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,338799000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,272000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,339071000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,339071000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q4,2019-10-01,2019-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,246072000.0
